chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound liver abnormal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/12. Pfizer. dose #1 06/02, Pfizer, dose #2 08/23 pt cc: fever, rhinorrea, left sided weakness , fatigue, cough, myalgias, chills, headache, exposure: unknown 08/25 COVID swab, result: detected 08/25 SARS-COV-2 Variant Sequencing result: pending 09/08 pt admit to medicine cc: SOB dx: COVID-19 complicated with multifocal pneumonia/pneumonitis, acute hypoxemic resp failure, bilateral pulmonary embolism (PEs). Likely secondary to COVID-19 infection, transaminitis/chemical and/or COVID-19 induced hepatitis LOS:9 days 09/08 COVID swab, result: detected 09/08 DDIMER result: 60.11 09/08 LACTIC ACID result: 1.72 09/08 ABG result: i-pH 7.52, i-Pco2 31, i-PO2 69, i-HCO3 25.6 09/08 troponin i result: 0.061 09/08 CTA PE impression: 1. Several segmental and numerous subsegmental acute pulmonary emboli. 2. Extensive patchy bilateral crazy paving type consolidation, nonspecific but likely in keeping with reported COVID 19. 3. Possible 7 mm nodule left upper lobe, consider 6 month follow-up. 4. Other findings as above. 09/09 SARS-COV-2 Variant Sequencing result: pending 09/09 FIBRINOGEN result: 491 09/09 DDIMER result: 26.69 09/09 ESR result: 9 09/10 FIBRINOGEN result: 399 09/10 DDIMER result: 13;30 09/10 procalcitonin result: 0.24 09/10 ESR result: 11 09/10 SARS-COV-2 Variant Sequencing result: pending 09/11 DDIMER result: 6.85 09/12 FIBRINOGEN result: 300 09/12 DDIMER result: 5.42 09/12 procalcintonin result: 0.14 09/12 ESR result: 19 09/13 DDMER result: 4.67 09/13 US LIVER impression: mild hepatomegaly. No sonographic evidence of hepatic steatosis or focal liver lesion. No intra or extrahepatic biliary ductal dilation. Small amount of gallbladder sludge. No cholelithiasis. 09/14 DDIMER result: 3.760 09/15 DDIMER result: 2.37 09/27 ALT/AST result: 99/39
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Vaccination failure
Clinical narrative: Narrative:  88YO MALE PATIENT self presented to local community hospital ER on 9/28/21 with covid infection. Pt died same day at hospital; Death 9/28/2021@1620. Date/Time of Admission: Sep 28,2021@00:01 Admitting Diagnosis: COVID Community Care Provider: HOSPITAL Patient self-presented to community emergency facility Emergency Notification Intake Date Presenting to the Facility: Sep 28,2021 Community Care Hospital Chief complaint: COVID Pt had received covid vaccines at local health dept on 6/?/2021 & 7/13/2021. Covid vaccine failure leading to covid infection on 9/28/21 and then pt's death from covid infection on same day, 9/28/2021.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Blood bicarbonate normal, Blood fibrinogen increased, Blood gases abnormal, COVID-19
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/11, Pfizer, dose #1 02/03, Pfizer, dose #2 08/17 pt cc: fatigue, myalgias, dyspnea exposure: unknown 08/25 pt admit to medicine cc: fever, chills, body aches, fatigue, malaise, cough and some SOB dx: covid 19 pneumonia LOS: 6 days 08/25 ABG i-pH 7.48, i-PCO2 33.4, i-PO2 68, i-HCO3 24.7 08/25 SARS-COV-2 Variant Sequencing result: pending 08/25 DDIMER result: 0.63 08/25 COVID swab, result: detected 08/25 CXR impression: Patchy lingular opacity. Correlate clinically for pneumonia, including viral/atypical etiology and follow-up to resolution. 08/26 CTA PE impression: No pulmonary embolus. Bilateral groundglass opacity, suspicious for bronchopneumonia and viral pneumonia is within differential. 08/26 FIBRINOGEN result: 638 08/26 DDIMER result: 0.96 08/26 ESR result: 51 08/27 FIBRINOGEN result: 541 08/27 DDIMER result: 0.53 08/27 ESR result: 43 08/28 S.PNEUMONIAE AG Eval result: negative 08/28 LEGIONELLAAgUR Eval result: negative 08/28 ESR result: 24 08/28 FIBRINOGEN result: 399 08/28 DDIMER result: 0.51 08/29 DDIMER result: 0.81 08/31 FIBRINOGEN result: 317 08/31 DDIMER result: 1.07 08/31 ESR result: 23
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Chills, Cough, Dyspnoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/11, Pfizer, dose #1 02/03, Pfizer, dose #2 08/17 pt cc: fatigue, myalgias, dyspnea exposure: unknown 08/25 pt admit to medicine cc: fever, chills, body aches, fatigue, malaise, cough and some SOB dx: covid 19 pneumonia LOS: 6 days 08/25 ABG i-pH 7.48, i-PCO2 33.4, i-PO2 68, i-HCO3 24.7 08/25 SARS-COV-2 Variant Sequencing result: pending 08/25 DDIMER result: 0.63 08/25 COVID swab, result: detected 08/25 CXR impression: Patchy lingular opacity. Correlate clinically for pneumonia, including viral/atypical etiology and follow-up to resolution. 08/26 CTA PE impression: No pulmonary embolus. Bilateral groundglass opacity, suspicious for bronchopneumonia and viral pneumonia is within differential. 08/26 FIBRINOGEN result: 638 08/26 DDIMER result: 0.96 08/26 ESR result: 51 08/27 FIBRINOGEN result: 541 08/27 DDIMER result: 0.53 08/27 ESR result: 43 08/28 S.PNEUMONIAE AG Eval result: negative 08/28 LEGIONELLAAgUR Eval result: negative 08/28 ESR result: 24 08/28 FIBRINOGEN result: 399 08/28 DDIMER result: 0.51 08/29 DDIMER result: 0.81 08/31 FIBRINOGEN result: 317 08/31 DDIMER result: 1.07 08/31 ESR result: 23
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Fibrin D dimer, Legionella test, Lung opacity, Malaise
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/11, Pfizer, dose #1 02/03, Pfizer, dose #2 08/17 pt cc: fatigue, myalgias, dyspnea exposure: unknown 08/25 pt admit to medicine cc: fever, chills, body aches, fatigue, malaise, cough and some SOB dx: covid 19 pneumonia LOS: 6 days 08/25 ABG i-pH 7.48, i-PCO2 33.4, i-PO2 68, i-HCO3 24.7 08/25 SARS-COV-2 Variant Sequencing result: pending 08/25 DDIMER result: 0.63 08/25 COVID swab, result: detected 08/25 CXR impression: Patchy lingular opacity. Correlate clinically for pneumonia, including viral/atypical etiology and follow-up to resolution. 08/26 CTA PE impression: No pulmonary embolus. Bilateral groundglass opacity, suspicious for bronchopneumonia and viral pneumonia is within differential. 08/26 FIBRINOGEN result: 638 08/26 DDIMER result: 0.96 08/26 ESR result: 51 08/27 FIBRINOGEN result: 541 08/27 DDIMER result: 0.53 08/27 ESR result: 43 08/28 S.PNEUMONIAE AG Eval result: negative 08/28 LEGIONELLAAgUR Eval result: negative 08/28 ESR result: 24 08/28 FIBRINOGEN result: 399 08/28 DDIMER result: 0.51 08/29 DDIMER result: 0.81 08/31 FIBRINOGEN result: 317 08/31 DDIMER result: 1.07 08/31 ESR result: 23
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, PCO2 decreased, PO2 decreased, Pain, Pneumonia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/11, Pfizer, dose #1 02/03, Pfizer, dose #2 08/17 pt cc: fatigue, myalgias, dyspnea exposure: unknown 08/25 pt admit to medicine cc: fever, chills, body aches, fatigue, malaise, cough and some SOB dx: covid 19 pneumonia LOS: 6 days 08/25 ABG i-pH 7.48, i-PCO2 33.4, i-PO2 68, i-HCO3 24.7 08/25 SARS-COV-2 Variant Sequencing result: pending 08/25 DDIMER result: 0.63 08/25 COVID swab, result: detected 08/25 CXR impression: Patchy lingular opacity. Correlate clinically for pneumonia, including viral/atypical etiology and follow-up to resolution. 08/26 CTA PE impression: No pulmonary embolus. Bilateral groundglass opacity, suspicious for bronchopneumonia and viral pneumonia is within differential. 08/26 FIBRINOGEN result: 638 08/26 DDIMER result: 0.96 08/26 ESR result: 51 08/27 FIBRINOGEN result: 541 08/27 DDIMER result: 0.53 08/27 ESR result: 43 08/28 S.PNEUMONIAE AG Eval result: negative 08/28 LEGIONELLAAgUR Eval result: negative 08/28 ESR result: 24 08/28 FIBRINOGEN result: 399 08/28 DDIMER result: 0.51 08/29 DDIMER result: 0.81 08/31 FIBRINOGEN result: 317 08/31 DDIMER result: 1.07 08/31 ESR result: 23
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Red blood cell sedimentation rate increased, SARS-CoV-2 test, SARS-CoV-2 test positive, Streptococcus test negative
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/11, Pfizer, dose #1 02/03, Pfizer, dose #2 08/17 pt cc: fatigue, myalgias, dyspnea exposure: unknown 08/25 pt admit to medicine cc: fever, chills, body aches, fatigue, malaise, cough and some SOB dx: covid 19 pneumonia LOS: 6 days 08/25 ABG i-pH 7.48, i-PCO2 33.4, i-PO2 68, i-HCO3 24.7 08/25 SARS-COV-2 Variant Sequencing result: pending 08/25 DDIMER result: 0.63 08/25 COVID swab, result: detected 08/25 CXR impression: Patchy lingular opacity. Correlate clinically for pneumonia, including viral/atypical etiology and follow-up to resolution. 08/26 CTA PE impression: No pulmonary embolus. Bilateral groundglass opacity, suspicious for bronchopneumonia and viral pneumonia is within differential. 08/26 FIBRINOGEN result: 638 08/26 DDIMER result: 0.96 08/26 ESR result: 51 08/27 FIBRINOGEN result: 541 08/27 DDIMER result: 0.53 08/27 ESR result: 43 08/28 S.PNEUMONIAE AG Eval result: negative 08/28 LEGIONELLAAgUR Eval result: negative 08/28 ESR result: 24 08/28 FIBRINOGEN result: 399 08/28 DDIMER result: 0.51 08/29 DDIMER result: 0.81 08/31 FIBRINOGEN result: 317 08/31 DDIMER result: 1.07 08/31 ESR result: 23
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Death, Dyspnoea exertional, Pleural effusion
Clinical narrative: Narrative:  Patient with hx of colon cancer with mets tot lung in treatment. Received First Moderna vaccine on 3/17/2021. Pt went to ER 3/30/2021 after approx 2 weeks of shortness of breath with exertion. He was diagnosed with CHF and Right Pleural effusion. On 4/28/2021 he got the 2nd Moderna Vaccine, on 5/1/2021 he returned to ER in worsening heart failure. Died on 5/2/2021
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Coma, Death, Intensive care, Life support, Myocardial infarction
Clinical narrative: Narrative:  74yo patient at outside community hospital died Oct 4,2021@01:22 from heart attack he had on 9/23/2021 after was placed on life support and was in a coma in the ICU. Wife was considering hospice but pt died prior to transferring to hospice. Pt had received covid vaccines on 1/8/21 & 2/5/21. Likely this death is not related to covid vaccines given patient's age, heart attack, and long length of time between date of vaccines and date of death.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: Narrative:  on 3/24/2021 and 4/19/2021 he received both Moderna vaccines in his left arm. On 6/26/2021 he had an unprovoked DVT in the left arm
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Lung neoplasm malignant
Clinical narrative: Narrative:  93yo male patient in home hospice care died of lung cancer on 9/16/2021. Pt had received covid vaccines on 3/3/21 & 4/2/21. Likely this death is not related to covid vaccines given patient's advanced age, cancer diagnosis in hospice care, and long length of time between date of vaccines and date of death.
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  first dose received 01/07/2021 second dose received 02/05/2021 patient tested positive on 09/25/2021
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  74yo with AFIB and other problems: Under care of multiple providers (SCT 20Hearing loss (SCT 15188001) Long-term current use of anticoagulant (Sacral back pain (SCT 61486003) Low back pain (SCT 279039007) History of total replacement of right hip joint (SCT 449141000124100) Artificial knee joint present (SCT 91100Paresthesia of foot (SCT 309087008) Tinnitus (SCT 60862001) Hearing loss (SCT 15188001) Essential hypertension (SCT 59621000) Hyperlipidemia (ICD-9-CM 272.4) Gout (ICD-9-CM 274.9) Gastroesophageal Reflux Disease (ICD-9-CM 530.81) History of repair of dissecting thoracicObese (ICD-9-CM 278.00) Deviated nasal septum (ICD-9-CM 470.) Varicose veins of lower extremity (ICD-9-CM 454.9) Osteoarthritis of Multiple Joints (ICD-9Pain due to knee joint prosthesis (ICD-9-CM 996.77) Benign prostatic hyperplasia (ICD-9-CM 6Proteinuria (ICD-9-CM 791.0) DIED on 9/13/2021. Pt had received covid vaccines on 2/22/21 & 3/22/21. Not able to assess if death is related as no info available about pt's death. Likely this death is not related given pt's age, comorbidities, & length of time between date of vaccines and date of death.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  80yo male pt residing in nursing home since 4/2021 died on 9/14/2021. No information given regarding pt's death. Likely death is not related to covid vaccine given on 1/14/2021 from outside agency given pt's advanced age & long time span between vaccine given date & date of death.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  70yo male with jaK 2 positive post polycythemic myelofibrosis with splenomegaly who sees NON-Agency providers died on 9/10/2021. Pt had received covid vaccines on 1/27/21 & 2/24/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and length of time between date of vaccines and date of death.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Cough, Diarrhoea, Dyspnoea
Clinical narrative: Narrative: 78yr patient tested positive COVID was scheduled MAT infusion though was found to tachycardia, COVID symptomatic (clinical condition deteriorated over a few days per family report) and sent to ED. COVID sx were present for ~ 10 days (fatigue, fever, HA, N/V, poor po intake, weakness, diarrhea, SOB, and cough. Was admitted to ICU for additional workup of tachycardia and hyponatremia (likely due to poor po intake/diarrhea). No COVID therapeutics were provided and no Oxygen supplementation. Hospitalized in ICU for non-COVID differential (hyponatremia, thrombocytopenia, and splenomegaly) for 9 days. Pertinent history: T2DM + meds, Afib, PAD, PVD, and aortic stenosis COVID Vaccination Status: Pfizer x 2 (Jan/Feb 2021)
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, General physical health deterioration, Headache, Hyponatraemia, Hypophagia
Clinical narrative: Narrative: 78yr patient tested positive COVID was scheduled MAT infusion though was found to tachycardia, COVID symptomatic (clinical condition deteriorated over a few days per family report) and sent to ED. COVID sx were present for ~ 10 days (fatigue, fever, HA, N/V, poor po intake, weakness, diarrhea, SOB, and cough. Was admitted to ICU for additional workup of tachycardia and hyponatremia (likely due to poor po intake/diarrhea). No COVID therapeutics were provided and no Oxygen supplementation. Hospitalized in ICU for non-COVID differential (hyponatremia, thrombocytopenia, and splenomegaly) for 9 days. Pertinent history: T2DM + meds, Afib, PAD, PVD, and aortic stenosis COVID Vaccination Status: Pfizer x 2 (Jan/Feb 2021)
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Intensive care, Malaise, Nausea, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: 78yr patient tested positive COVID was scheduled MAT infusion though was found to tachycardia, COVID symptomatic (clinical condition deteriorated over a few days per family report) and sent to ED. COVID sx were present for ~ 10 days (fatigue, fever, HA, N/V, poor po intake, weakness, diarrhea, SOB, and cough. Was admitted to ICU for additional workup of tachycardia and hyponatremia (likely due to poor po intake/diarrhea). No COVID therapeutics were provided and no Oxygen supplementation. Hospitalized in ICU for non-COVID differential (hyponatremia, thrombocytopenia, and splenomegaly) for 9 days. Pertinent history: T2DM + meds, Afib, PAD, PVD, and aortic stenosis COVID Vaccination Status: Pfizer x 2 (Jan/Feb 2021)
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Splenomegaly, Tachycardia, Thrombocytopenia, Vomiting
Clinical narrative: Narrative: 78yr patient tested positive COVID was scheduled MAT infusion though was found to tachycardia, COVID symptomatic (clinical condition deteriorated over a few days per family report) and sent to ED. COVID sx were present for ~ 10 days (fatigue, fever, HA, N/V, poor po intake, weakness, diarrhea, SOB, and cough. Was admitted to ICU for additional workup of tachycardia and hyponatremia (likely due to poor po intake/diarrhea). No COVID therapeutics were provided and no Oxygen supplementation. Hospitalized in ICU for non-COVID differential (hyponatremia, thrombocytopenia, and splenomegaly) for 9 days. Pertinent history: T2DM + meds, Afib, PAD, PVD, and aortic stenosis COVID Vaccination Status: Pfizer x 2 (Jan/Feb 2021)
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, COVID-19, Dyspnoea, Fibrin D dimer, Oropharyngeal pain
Clinical narrative: Narrative:  Patient presented to the ED on 10/1/20212 due to shortness of breath, sore throat, and fever. He initially tested positive on 9/27/2021. On arrival, his SpO2 was 85% on Room Air. 2LPM were place and SpO2 increased to 96%. D-dimer positive (0.8) and CRP was elevated (CRP 20.84). He was admitted to the Medical COVID Unit. Dexamethasone and remdesivir initiated for treatment of COVID-19.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient presented to the ED on 10/1/20212 due to shortness of breath, sore throat, and fever. He initially tested positive on 9/27/2021. On arrival, his SpO2 was 85% on Room Air. 2LPM were place and SpO2 increased to 96%. D-dimer positive (0.8) and CRP was elevated (CRP 20.84). He was admitted to the Medical COVID Unit. Dexamethasone and remdesivir initiated for treatment of COVID-19.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, COVID-19, Chest X-ray abnormal, Diarrhoea, Dyspnoea
Clinical narrative: Narrative: 76 yo male with PMH of OSA, AAA, DM, HTN, and HLP presented to the emergency department department with a week of fever fatigue, exertional dyspnea dyspnea, and diarrhea. He was also concerned about his blood pressures being elevated. In the emergency department he was found to be Covid positive despite having been previously vaccinated. Chest x-ray showed a left basilar pneumonia, however procalcitonin was negative, there is no leukocytosis, and patient did not have a fever. Patient was initially given antibiotics however given unremarkable lab findings was felt that this was likely pneumonia secondary to COVID-19 and not bacterial infection. Antibiotics were discontinued. Pt was admitted for monitoring and discharged the next day.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea exertional, Fatigue, Laboratory test normal, Pneumonia, Procalcitonin normal
Clinical narrative: Narrative: 76 yo male with PMH of OSA, AAA, DM, HTN, and HLP presented to the emergency department department with a week of fever fatigue, exertional dyspnea dyspnea, and diarrhea. He was also concerned about his blood pressures being elevated. In the emergency department he was found to be Covid positive despite having been previously vaccinated. Chest x-ray showed a left basilar pneumonia, however procalcitonin was negative, there is no leukocytosis, and patient did not have a fever. Patient was initially given antibiotics however given unremarkable lab findings was felt that this was likely pneumonia secondary to COVID-19 and not bacterial infection. Antibiotics were discontinued. Pt was admitted for monitoring and discharged the next day.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative: 76 yo male with PMH of OSA, AAA, DM, HTN, and HLP presented to the emergency department department with a week of fever fatigue, exertional dyspnea dyspnea, and diarrhea. He was also concerned about his blood pressures being elevated. In the emergency department he was found to be Covid positive despite having been previously vaccinated. Chest x-ray showed a left basilar pneumonia, however procalcitonin was negative, there is no leukocytosis, and patient did not have a fever. Patient was initially given antibiotics however given unremarkable lab findings was felt that this was likely pneumonia secondary to COVID-19 and not bacterial infection. Antibiotics were discontinued. Pt was admitted for monitoring and discharged the next day.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, COVID-19, Dyspnoea, Electrocardiogram normal, Intensive care
Clinical narrative: Narrative:  Patient presented to the ED on 9/28/2021 with chief complaint of sudden onset of shortness of breath and shortness of breath. Initial troponin was 0.19. EKG was negative for ischemic changes. Repeat troponin increased to 0.26. Patient tested POSITIVE for COVID. He was declined for transfer to cath lab due to COVID status. He was diagnosed with NSTEMI and admitted to ICU for close monitoring. On day #2 of hospitalization, Patient develop diffuse body aches and mild fever. He did not require oxygen and was not placed on dexamethasone or remdesivir.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Narrative:  Patient presented to the ED on 9/28/2021 with chief complaint of sudden onset of shortness of breath and shortness of breath. Initial troponin was 0.19. EKG was negative for ischemic changes. Repeat troponin increased to 0.26. Patient tested POSITIVE for COVID. He was declined for transfer to cath lab due to COVID status. He was diagnosed with NSTEMI and admitted to ICU for close monitoring. On day #2 of hospitalization, Patient develop diffuse body aches and mild fever. He did not require oxygen and was not placed on dexamethasone or remdesivir.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  97yo male patient who does not receive care from agency died on 9/10/2021. No medical information in pt's chart except pt did receive one covid vaccine from pharmacy on 1/14/2021. Likely this death is not related given patient's advanced age, and length of time between date of vaccine and date of death.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, SARS-CoV-2 test positive
Clinical narrative: Narrative:  59 yo male with PMH of OSA, low back pain, HTN, DVT, PE, thrombocytopenia, HTN, leukopenia, and obesity presented to emergency department for 1 week of increasing shortness of breath cough and fatigue at the time was found to be COVID positive. Also had new oxygen requirement. Initially requiring 4 L of oxygen, at times during hospitalization required up to almost 10 L of oxygen for temporary amount of time. Started on dexamethasone and remdesivir at admission. Due to increasing oxygen requirements with started on Baritucinab on 913. Patient is not on Lasix at home, however over the course of the hospitalization he received 40 mg of IV Lasix on multiple occasions,this helped with respiratory status. On day of discharge patient completed 6- minute walk test. This showed oxygen requirement of 2 L at rest and 4 L with exertion.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, COVID-19, Dyspnoea, Electrocardiogram abnormal, Exposure to SARS-CoV-2
Clinical narrative: Narrative:  62-year-old male with PMH of AFib, weight loss, BPH, chronic back pain, GERD, metastatic carcinoid tumor, liver mass presented to the ED on 4/22/2021 with shortness of breath and productive cough that had worsened over the past several days. He had a known COVID-19 exposure within 1 week of being seen. He had received his COVID-19 vaccinations in Nov/Dec 2020, but with his worsening symptoms wanted to be evaluated. Initial workup was pertinent for COVID-19 + test and EKG demonstrating atrial fibrillation with rapid ventricular response. He was placed on diltiazem gtt with heart rates decreasing to the 70s and was admitted to the ICU. After one night in the ICU, the patient converted back into normal sinus rhythm, and was transitioned to oral diltiazem. Patient was subsequently transferred to the floor for further cares. Patient did not require supplemental oxygen throughout his hospital stay. However, due to his clinical condition being borderline high risk, the patient received antibody infusions for his COVID-19 infection.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Productive cough, SARS-CoV-2 test positive
Clinical narrative: Narrative:  62-year-old male with PMH of AFib, weight loss, BPH, chronic back pain, GERD, metastatic carcinoid tumor, liver mass presented to the ED on 4/22/2021 with shortness of breath and productive cough that had worsened over the past several days. He had a known COVID-19 exposure within 1 week of being seen. He had received his COVID-19 vaccinations in Nov/Dec 2020, but with his worsening symptoms wanted to be evaluated. Initial workup was pertinent for COVID-19 + test and EKG demonstrating atrial fibrillation with rapid ventricular response. He was placed on diltiazem gtt with heart rates decreasing to the 70s and was admitted to the ICU. After one night in the ICU, the patient converted back into normal sinus rhythm, and was transitioned to oral diltiazem. Patient was subsequently transferred to the floor for further cares. Patient did not require supplemental oxygen throughout his hospital stay. However, due to his clinical condition being borderline high risk, the patient received antibody infusions for his COVID-19 infection.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Chills, Cough, Dyspnoea, Hypotension
Clinical narrative: Narrative:  76yr patient presented to ED on 9/27 concerns for SOB, fever, chills, cough, tachycardic, and hypotensive. COVID tested positive with elevated Trop. Differential diagnosis: likely type 2 NSTEMI in setting of COVID; admitted to the ICU for further management. Was not requiring O2 until late evening of 9/28 (4L via oxymask) then next day able to wean to 2L then off. COVID Therapeutics: dexamethasone 6mg po daily (x 2 doses) Inpatient stay: 2 days PMH: psoriatic arthritis, myelodysplastic syndrome, AS, and gerd along with taking immunosuppressant medications (prednisone 7.5mg daily. COVID vaccinations (Moderna x 2 including 3rd dose; 1/20/21, 2/17/2021, and 9/21/2021)
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Intensive care, Pyrexia, SARS-CoV-2 test positive, Tachycardia, Troponin increased
Clinical narrative: Narrative:  76yr patient presented to ED on 9/27 concerns for SOB, fever, chills, cough, tachycardic, and hypotensive. COVID tested positive with elevated Trop. Differential diagnosis: likely type 2 NSTEMI in setting of COVID; admitted to the ICU for further management. Was not requiring O2 until late evening of 9/28 (4L via oxymask) then next day able to wean to 2L then off. COVID Therapeutics: dexamethasone 6mg po daily (x 2 doses) Inpatient stay: 2 days PMH: psoriatic arthritis, myelodysplastic syndrome, AS, and gerd along with taking immunosuppressant medications (prednisone 7.5mg daily. COVID vaccinations (Moderna x 2 including 3rd dose; 1/20/21, 2/17/2021, and 9/21/2021)
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Bacterial test positive, Body temperature increased, COVID-19, Chest X-ray normal, Chills
Clinical narrative: Narrative: 86 year old male with PMH of afib, complete heart block s/p pacemaker placement, HLD, HTN, CKD4, prostate cancer, gastric caner s/p distalgastrectomy with GJ anastomosis, leiomyosarcoma of upper GI tract on Gleevec  presented to the ED with 2 days history of chills, fatigue, mild shortness of breath and mild productive cough, this morning the patient took his temp and it was 100.4 so he decided to come to the ED. in the ED his vitals were stable, his X-ray showed no acute cardiopulmonary process, on the 7/29 he provided a uring sample that showed UTI and the culture grew Aerococcus which was not followed. The patient tested positive for COVID-19 in the ED, so the ED physician wanted to admit him for COVID-19 and UTI. Patient did not require oxygen. Ciprofloxacin was changed to Cephalexin due to QTc prolongation concerns.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Culture urine positive, Dyspnoea, Fatigue, Productive cough, SARS-CoV-2 test positive
Clinical narrative: Narrative: 86 year old male with PMH of afib, complete heart block s/p pacemaker placement, HLD, HTN, CKD4, prostate cancer, gastric caner s/p distalgastrectomy with GJ anastomosis, leiomyosarcoma of upper GI tract on Gleevec  presented to the ED with 2 days history of chills, fatigue, mild shortness of breath and mild productive cough, this morning the patient took his temp and it was 100.4 so he decided to come to the ED. in the ED his vitals were stable, his X-ray showed no acute cardiopulmonary process, on the 7/29 he provided a uring sample that showed UTI and the culture grew Aerococcus which was not followed. The patient tested positive for COVID-19 in the ED, so the ED physician wanted to admit him for COVID-19 and UTI. Patient did not require oxygen. Ciprofloxacin was changed to Cephalexin due to QTc prolongation concerns.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary tract infection, Urine analysis abnormal
Clinical narrative: Narrative: 86 year old male with PMH of afib, complete heart block s/p pacemaker placement, HLD, HTN, CKD4, prostate cancer, gastric caner s/p distalgastrectomy with GJ anastomosis, leiomyosarcoma of upper GI tract on Gleevec  presented to the ED with 2 days history of chills, fatigue, mild shortness of breath and mild productive cough, this morning the patient took his temp and it was 100.4 so he decided to come to the ED. in the ED his vitals were stable, his X-ray showed no acute cardiopulmonary process, on the 7/29 he provided a uring sample that showed UTI and the culture grew Aerococcus which was not followed. The patient tested positive for COVID-19 in the ED, so the ED physician wanted to admit him for COVID-19 and UTI. Patient did not require oxygen. Ciprofloxacin was changed to Cephalexin due to QTc prolongation concerns.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Anaemia, COVID-19, Chest X-ray abnormal, Chest discomfort, Cough
Clinical narrative: Narrative:  64 year old male with past medical history of liver/renal transplant in 2019 due to HCV/cirrhosis, diabetes mellitus 2, hypertension, hyperlipidemia, borderline personality disorder, venous insufficiency, and HFpEF presented to the ED for a fever. Then in the ED he was found to be positive for COVID-19. Of note he was fully vaccinated in 1/2021-2/2021 with Pfizer. Other than his fever he had experienced some cough, clear sputum production, and some increased chest tightness for the past 2-3 days. Work-up in the ED was significant for CXR that showed slight opacity of the left costophrenic area but vastly unchanged and then stable anemia/thrombocytopenia. His O2 saturations were >90% and remained >90% during hospitalization apart from during sleep which was suspected to be due untreated OSA. With his overall symptoms being indicative of a mild episode of COVID-19 he was given casirivimab/imdevimib for treatment. He was then admitted to internal medicine due to inability to return to care facility due to quarantine procedures. Once admitted to the floor contact was made with his transplant surgeon and it was determined to hold his mycophenolate for the next two weeks. On 8/17 he was experienced significant wheezing which improved with scheduled albuterol. Throughout 8/18-19 his cough, shortness of breath and sputum production improved. His oxygen saturations remained above goal while he was awake. Remdesivir and dexamethasone was clear by his transplant team but was never given due to his mild symptoms and able to maintain his oxygen saturations. On 8/19, it was determined that he could return to his care facility. He was hemodynamically stable to determined safe to discharge back to his care facility.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Laboratory test abnormal, Lung opacity, Obstructive sleep apnoea syndrome, Productive cough
Clinical narrative: Narrative:  64 year old male with past medical history of liver/renal transplant in 2019 due to HCV/cirrhosis, diabetes mellitus 2, hypertension, hyperlipidemia, borderline personality disorder, venous insufficiency, and HFpEF presented to the ED for a fever. Then in the ED he was found to be positive for COVID-19. Of note he was fully vaccinated in 1/2021-2/2021 with Pfizer. Other than his fever he had experienced some cough, clear sputum production, and some increased chest tightness for the past 2-3 days. Work-up in the ED was significant for CXR that showed slight opacity of the left costophrenic area but vastly unchanged and then stable anemia/thrombocytopenia. His O2 saturations were >90% and remained >90% during hospitalization apart from during sleep which was suspected to be due untreated OSA. With his overall symptoms being indicative of a mild episode of COVID-19 he was given casirivimab/imdevimib for treatment. He was then admitted to internal medicine due to inability to return to care facility due to quarantine procedures. Once admitted to the floor contact was made with his transplant surgeon and it was determined to hold his mycophenolate for the next two weeks. On 8/17 he was experienced significant wheezing which improved with scheduled albuterol. Throughout 8/18-19 his cough, shortness of breath and sputum production improved. His oxygen saturations remained above goal while he was awake. Remdesivir and dexamethasone was clear by his transplant team but was never given due to his mild symptoms and able to maintain his oxygen saturations. On 8/19, it was determined that he could return to his care facility. He was hemodynamically stable to determined safe to discharge back to his care facility.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Thrombocytopenia, Wheezing
Clinical narrative: Narrative:  64 year old male with past medical history of liver/renal transplant in 2019 due to HCV/cirrhosis, diabetes mellitus 2, hypertension, hyperlipidemia, borderline personality disorder, venous insufficiency, and HFpEF presented to the ED for a fever. Then in the ED he was found to be positive for COVID-19. Of note he was fully vaccinated in 1/2021-2/2021 with Pfizer. Other than his fever he had experienced some cough, clear sputum production, and some increased chest tightness for the past 2-3 days. Work-up in the ED was significant for CXR that showed slight opacity of the left costophrenic area but vastly unchanged and then stable anemia/thrombocytopenia. His O2 saturations were >90% and remained >90% during hospitalization apart from during sleep which was suspected to be due untreated OSA. With his overall symptoms being indicative of a mild episode of COVID-19 he was given casirivimab/imdevimib for treatment. He was then admitted to internal medicine due to inability to return to care facility due to quarantine procedures. Once admitted to the floor contact was made with his transplant surgeon and it was determined to hold his mycophenolate for the next two weeks. On 8/17 he was experienced significant wheezing which improved with scheduled albuterol. Throughout 8/18-19 his cough, shortness of breath and sputum production improved. His oxygen saturations remained above goal while he was awake. Remdesivir and dexamethasone was clear by his transplant team but was never given due to his mild symptoms and able to maintain his oxygen saturations. On 8/19, it was determined that he could return to his care facility. He was hemodynamically stable to determined safe to discharge back to his care facility.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Narrative:  84 yo patient with a significant PMHx of COPD, CKD Stage III, HTN presented to ED for SOB. Due to needing O2 in the ED, he was not a candidate for Regeneron therapy. He was admitted to the floor where he was requiring up to 4L of oxygen. Was started on Remdesivir and Dexamethasone. He was discharged on Dexamethasone for 10 days and home oxygen after he received a 6MW study prior to discharge. On the day of discharge the patient was medically stable and requiring 1.5 L O2 and will be picked up by his wife.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Ataxia, COVID-19, Decreased appetite, Gait disturbance
Clinical narrative: Narrative:  72 y/o M with PMHx of Alzheimer's dementia, depression, HLD, and GERD admitted for generalized weakness, anorexia, ataxia, and productive cough . Pt was found to be COVID positive on admission. Symptoms were likely secondary to poor oral intake and COVID-19 infection. Pt was started on 5-day course of Azithromycin to help combat inflammatory changes typically seen with COVID-19 and cover any common bacterial sources of pneumonia. Pt had good oral intake and was given a total of 2L LR over 24 hours which resolved lactic acidosis and stabilized all signs of severe sepsis. Additionally, pt never experienced any respiratory symptoms of SOB or dyspnea. He complained of productive cough with white sputum but mentioned that this is chronic for him. Did not require any oxygen requirements during hospitalization and saturated between 93-95% on room air. On neuro exam, pt never had any focal deficits or motor strength weakness (5/5 strength in all extremities) but did show a little unsteadiness while walking to and from the bathroom. PT and OT evaluated the pt and had no concerns with current condition and equipment/support at home.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Hypophagia, Inflammation, Lactic acidosis, Pneumonia bacterial, Productive cough
Clinical narrative: Narrative:  72 y/o M with PMHx of Alzheimer's dementia, depression, HLD, and GERD admitted for generalized weakness, anorexia, ataxia, and productive cough . Pt was found to be COVID positive on admission. Symptoms were likely secondary to poor oral intake and COVID-19 infection. Pt was started on 5-day course of Azithromycin to help combat inflammatory changes typically seen with COVID-19 and cover any common bacterial sources of pneumonia. Pt had good oral intake and was given a total of 2L LR over 24 hours which resolved lactic acidosis and stabilized all signs of severe sepsis. Additionally, pt never experienced any respiratory symptoms of SOB or dyspnea. He complained of productive cough with white sputum but mentioned that this is chronic for him. Did not require any oxygen requirements during hospitalization and saturated between 93-95% on room air. On neuro exam, pt never had any focal deficits or motor strength weakness (5/5 strength in all extremities) but did show a little unsteadiness while walking to and from the bathroom. PT and OT evaluated the pt and had no concerns with current condition and equipment/support at home.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Sputum discoloured
Clinical narrative: Narrative:  72 y/o M with PMHx of Alzheimer's dementia, depression, HLD, and GERD admitted for generalized weakness, anorexia, ataxia, and productive cough . Pt was found to be COVID positive on admission. Symptoms were likely secondary to poor oral intake and COVID-19 infection. Pt was started on 5-day course of Azithromycin to help combat inflammatory changes typically seen with COVID-19 and cover any common bacterial sources of pneumonia. Pt had good oral intake and was given a total of 2L LR over 24 hours which resolved lactic acidosis and stabilized all signs of severe sepsis. Additionally, pt never experienced any respiratory symptoms of SOB or dyspnea. He complained of productive cough with white sputum but mentioned that this is chronic for him. Did not require any oxygen requirements during hospitalization and saturated between 93-95% on room air. On neuro exam, pt never had any focal deficits or motor strength weakness (5/5 strength in all extremities) but did show a little unsteadiness while walking to and from the bathroom. PT and OT evaluated the pt and had no concerns with current condition and equipment/support at home.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram abnormal, Arteriosclerosis, Blindness, Cardiac monitoring, Cerebrovascular accident
Clinical narrative: Narrative: Patient had RIGHT occipital subacute stroke with symptoms started within a day of receiving COVID 19 moderna 9/21/2021. Patient attempted to wait at home for symptoms to resolve but subsequently presented 9/2/2021 to urgent care for visual field loss and found to have subacute occipital stroke. He was transferred to hospital and seen by neurology. Attempted w/u to determine etiology. ECHO was WNL. cardiac monitoring unclear. MRI confirmed prior infarcts and occipital CVA. MRA neck showed 60-70% atherosclerotic disease. Appears patient had 2 doses of plavix and then left AMA. No rx were written and no clear recommendations. During interim cardiology and neurology consultations were placed pending scheduling. Patient reports continued visual loss but not unchanged, thinks it is staying the same and potentially getter better. Discussed this case with pharmacy. Will continue max dose rosuvastatin 40mg as appropriate therapy. Patient has been compliant with daily baby aspirin. Will increase to 325mg daily aspiring (instructed to take 4 of the 81 mg aspirin daily until received requesting overnight delivery). Decision making with patient on adding pavix to regiment and risks and benefits discussed. Will add plavix 75mg daily x 21 days and then to be determined by neurology followup continued antiplatelet therapy. Addition of LDCT scan and PFT testing as DX of COPD not on problem list but noted emphysema and smokes pipe- recommended cessation patient seems reluctant understands this is a risk factor for recurrent CVA. Pipe tobacco smoker 4-5 bowls/day > 30 years. Added COPD to problem list. Patient has risk factors and prior old infarcts as determined by brain imagine.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Echocardiogram normal, Emphysema, Magnetic resonance imaging head abnormal, Pulmonary function test abnormal
Clinical narrative: Narrative: Patient had RIGHT occipital subacute stroke with symptoms started within a day of receiving COVID 19 moderna 9/21/2021. Patient attempted to wait at home for symptoms to resolve but subsequently presented 9/2/2021 to urgent care for visual field loss and found to have subacute occipital stroke. He was transferred to hospital and seen by neurology. Attempted w/u to determine etiology. ECHO was WNL. cardiac monitoring unclear. MRI confirmed prior infarcts and occipital CVA. MRA neck showed 60-70% atherosclerotic disease. Appears patient had 2 doses of plavix and then left AMA. No rx were written and no clear recommendations. During interim cardiology and neurology consultations were placed pending scheduling. Patient reports continued visual loss but not unchanged, thinks it is staying the same and potentially getter better. Discussed this case with pharmacy. Will continue max dose rosuvastatin 40mg as appropriate therapy. Patient has been compliant with daily baby aspirin. Will increase to 325mg daily aspiring (instructed to take 4 of the 81 mg aspirin daily until received requesting overnight delivery). Decision making with patient on adding pavix to regiment and risks and benefits discussed. Will add plavix 75mg daily x 21 days and then to be determined by neurology followup continued antiplatelet therapy. Addition of LDCT scan and PFT testing as DX of COPD not on problem list but noted emphysema and smokes pipe- recommended cessation patient seems reluctant understands this is a risk factor for recurrent CVA. Pipe tobacco smoker 4-5 bowls/day > 30 years. Added COPD to problem list. Patient has risk factors and prior old infarcts as determined by brain imagine.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cough, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Narrative:  50M with PMH MS, HLD, BPH, psoriasis, ED who presented to local hospital on 8/22/2021 for weakness and cough, was found to be positive with COVID19, pt was transferred to the local hospital for continued care. Prior to admission, patient had not required supplemental oxygen. Of note, this patient was COVID19 + in Nov 20202 and was hospitalized for almost 1 month (ICU, HFNC, he did not require intubation). Patient received both Moderna vaccines (March and April 2021). On day 2 of admission patient did require supplemental oxygen up to 4L NC for hypoxic respiratory failure. He was started on remdesivir and dexamethasone therapy. He finished a 5 day course of remdesivir, will finish dexamethasoen 9/3. Prior to d/c patient had walk test with RT and was found to not require supplemental oxygen.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Walking distance test normal
Clinical narrative: Narrative:  50M with PMH MS, HLD, BPH, psoriasis, ED who presented to local hospital on 8/22/2021 for weakness and cough, was found to be positive with COVID19, pt was transferred to the local hospital for continued care. Prior to admission, patient had not required supplemental oxygen. Of note, this patient was COVID19 + in Nov 20202 and was hospitalized for almost 1 month (ICU, HFNC, he did not require intubation). Patient received both Moderna vaccines (March and April 2021). On day 2 of admission patient did require supplemental oxygen up to 4L NC for hypoxic respiratory failure. He was started on remdesivir and dexamethasone therapy. He finished a 5 day course of remdesivir, will finish dexamethasoen 9/3. Prior to d/c patient had walk test with RT and was found to not require supplemental oxygen.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Endotracheal intubation, Inappropriate schedule of product administration
Clinical narrative: Narrative:  there was a delay in getting his second dose. First dose was 3/13/21. Unclear why he didn't get 2nd dose at appropriate time. Pt received first dose prior to being admitted with HBPC. Pt admitted to outside hospital 8/26 for cardiac arrest and became intubated.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Dyspnoea, Fatigue, Loss of personal independence in daily activities
Clinical narrative: Narrative:  74 yr old male with PMH for COVID-19 diagnosed on 8-19, OSA, obesity, HTN, HLD, CAD s/p stenting, HFpEF (60-65%), OSA on CPAP, Insulin independent DMII, CML, and COPD presented to ER with increased shortness of breath and fatigue. Pt received both doses of Moderna in the community. Patient stated that since being diagnosed with COVID-19 on 8-19, he has had increased shortness of breath, more fatigue, and had reduced abilities to do activities of daily living. Pt did not require oxygen during his hospital course. He was given dexamethasone for covid19 treatment. On 8/28, he was found to have PE and was started on lovenox, discharged on apixaban, discharged 8/31/2021.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, Chest X-ray abnormal, Decreased appetite, Dyspnoea
Clinical narrative: Narrative:  86-year-old male with a history of chronic systolic heart failure and chronic kidney disease stage III presented to emergency department with 2 weeks of worsening shortness of breath and anorexia. On evaluation he was found to have an elevated BNP, slight elevation in troponin to 0.07 without change in EKG from baseline, and a chest x-ray that was clear except for a spiculated mass that is being followed with CT on an outpatient basis. With these findings the patient was given a loading dose of aspirin and started on IV Lasix; cardiology was consulted. The patient was then found to be Covid positive and was admitted to a contact precaution room. The patient required no supplemental O2 and was saturating well on room air. It is speculated that the patient's milder than expected course of COVID-19 is secondary to being fully vaccinated. On hospital day 2, the patient was doing well without any acute events and no new or worsening symptoms. H